Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Bausch & Lomb Corp (BLCO)

Bausch & Lomb Corp (BLCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Healthcare - pexels-anna-shvets-3683047 Pharmacy
This Bausch Health Companies Unusually Active Option Is a No-Brainer Barchart - Thu Mar 28, 12:00PM CDT

Bausch Health Companies had the 8th-highest Vol/OI ratio in Wednesday trading. The pharmaceutical company’s unusual options activity suggests it might have more gains ahead.

BHC : 6.88 (-1.01%)
BLCO : 15.41 (+0.78%)
Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030 FinancialNewsMedia - Fri Sep 8, 2023

EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(OTCQX:RHHBY) EQNX::TICKER_END

OKYO : 1.4600 (-3.31%)
ALC : 82.01 (+0.68%)
BLCO : 15.41 (+0.78%)
JNJ : 149.91 (+0.04%)
RHHBY : 30.9500 (+0.16%)
Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030 PR Newswire - Fri Sep 8, 2023

/PRNewswire/ -- The Global Dry Eye Syndrome market has been growing substantially in the past years and is expected to continue through 2030. Dry Eye Syndrome...

OKYO : 1.4600 (-3.31%)
ALC : 82.01 (+0.68%)
BLCO : 15.41 (+0.78%)
JNJ : 149.91 (+0.04%)
RHHBY : 30.9500 (+0.16%)
Bausch + Lomb Announces First-Quarter 2023 Results and Provides 2023 Guidance Business Wire - Wed May 3, 2023

Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”, “we” or “our”), a leading global eye health company dedicated to helping people see better to live better,...

BLCO : 15.41 (+0.78%)
BLCO.TO : 21.10 (+1.59%)
Bausch + Lomb Releases Annual Environmental, Social and Governance Report Business Wire - Mon May 1, 2023

Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”, “we” or “our”), a leading global eye health company dedicated to helping people see better to live better,...

BLCO : 15.41 (+0.78%)
BLCO.TO : 21.10 (+1.59%)
Bausch + Lomb Announces the Presentation of New Scientific Data on Products and Pipeline Programs at the American Society of Cataract and Refractive Surgery Annual Meeting Business Wire - Wed Apr 26, 2023

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of 21 podium...

BLCO : 15.41 (+0.78%)
BLCO.TO : 21.10 (+1.59%)
Bausch + Lomb Announces 2023 Annual Meeting of Shareholder Results Business Wire - Tue Apr 25, 2023

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live better, today announced the election...

BLCO : 15.41 (+0.78%)
BLCO.TO : 21.10 (+1.59%)
Bausch + Lomb Announces U.S. Launch of StableVisc™ Cohesive Ophthalmic Viscosurgical Device and TotalVisc™ Viscoelastic System Business Wire - Mon Apr 24, 2023

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of StableVisc™...

BLCO : 15.41 (+0.78%)
BLCO.TO : 21.10 (+1.59%)
Bausch + Lomb Announces the Presentation of New Data on Products and Pipeline Programs at the Association for Research in Vision and Ophthalmology Meeting Business Wire - Thu Apr 20, 2023

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of eight scientific...

BLCO : 15.41 (+0.78%)
BLCO.TO : 21.10 (+1.59%)
Bausch + Lomb Reports More Than 65 Million Units of Contact Lens, Eye Care and Lens Care Materials Recycled Through ONE by ONE and Biotrue® Eye Care Recycling Programs Business Wire - Tue Apr 18, 2023

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced its exclusive ONE by ONE and...

BLCO : 15.41 (+0.78%)
BLCO.TO : 21.10 (+1.59%)

Barchart Exclusives

3 Reasons This Mega-Cap Stock Will Continue to Soar in 2024 and Beyond Barchart - 1 hour ago
Despite the stiff competition, Wall Street believes Netflix will continue to rule the streaming space. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot